Discovery and Pharmacological Characterization of JNJ-42756493 (Erdafitinib), a Functionally Selective Small-Molecule FGFR Family InhibitorTimothy Perera, Matthew V. Lorenzi|Molecular Cancer Therapeutics|2017Cited by 338
Modular phase I/II clinical trial evaluating the selective MET-kinase inhibitor OMO-1 in patients with advanced malignancies: Safety and proof of mechanism.Martijn P. Lolkema, Sarah P. Blagden, Filip De Vos et al.|Journal of Clinical Oncology|2019Cited by 1